UBS Maintains Buy on Cardinal Health, Raises Price Target to $295
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice TargetHot
UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $280 to $295.
UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $280 to $295.